These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 22711708)

  • 1. Inhibition of the Kit ligand/c-Kit axis attenuates metastasis in a mouse model mimicking local breast cancer relapse after radiotherapy.
    Kuonen F; Laurent J; Secondini C; Lorusso G; Stehle JC; Rausch T; Faes-Van't Hull E; Bieler G; Alghisi GC; Schwendener R; Andrejevic-Blant S; Mirimanoff RO; Rüegg C
    Clin Cancer Res; 2012 Aug; 18(16):4365-74. PubMed ID: 22711708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral administration of benzyl-isothiocyanate inhibits solid tumor growth and lung metastasis of 4T1 murine mammary carcinoma cells in BALB/c mice.
    Kim EJ; Hong JE; Eom SJ; Lee JY; Park JH
    Breast Cancer Res Treat; 2011 Nov; 130(1):61-71. PubMed ID: 21170677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antioxidant N-acetylcysteine prevents HIF-1 stabilization under hypoxia in vitro but does not affect tumorigenesis in multiple breast cancer models in vivo.
    Sceneay J; Liu MC; Chen A; Wong CS; Bowtell DD; Möller A
    PLoS One; 2013; 8(6):e66388. PubMed ID: 23840457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Licochalcone E present in licorice suppresses lung metastasis in the 4T1 mammary orthotopic cancer model.
    Kwon SJ; Park SY; Kwon GT; Lee KW; Kang YH; Choi MS; Yun JW; Jeon JH; Jun JG; Park JH
    Cancer Prev Res (Phila); 2013 Jun; 6(6):603-13. PubMed ID: 23625311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors.
    Lou Y; McDonald PC; Oloumi A; Chia S; Ostlund C; Ahmadi A; Kyle A; Auf dem Keller U; Leung S; Huntsman D; Clarke B; Sutherland BW; Waterhouse D; Bally M; Roskelley C; Overall CM; Minchinton A; Pacchiano F; Carta F; Scozzafava A; Touisni N; Winum JY; Supuran CT; Dedhar S
    Cancer Res; 2011 May; 71(9):3364-76. PubMed ID: 21415165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppressive effects of a proton beam on tumor growth and lung metastasis through the inhibition of metastatic gene expression in 4T1 orthotopic breast cancer model.
    Kwon YS; Lee KS; Chun SY; Jang TJ; Nam KS
    Int J Oncol; 2016 Jul; 49(1):336-42. PubMed ID: 27176787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An novel inhibitor of TGF-β type I receptor, IN-1130, blocks breast cancer lung metastasis through inhibition of epithelial-mesenchymal transition.
    Park CY; Min KN; Son JY; Park SY; Nam JS; Kim DK; Sheen YY
    Cancer Lett; 2014 Aug; 351(1):72-80. PubMed ID: 24887560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Premetastatic soil and prevention of breast cancer brain metastasis.
    Liu Y; Kosaka A; Ikeura M; Kohanbash G; Fellows-Mayle W; Snyder LA; Okada H
    Neuro Oncol; 2013 Jul; 15(7):891-903. PubMed ID: 23595625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of breast cancer growth and metastasis by a biomimetic peptide.
    Lee E; Lee SJ; Koskimaki JE; Han Z; Pandey NB; Popel AS
    Sci Rep; 2014 Nov; 4():7139. PubMed ID: 25409905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratumoral expression of mature human neutrophil peptide-1 potentiates the therapeutic effect of doxorubicin in a mouse 4T1 breast cancer model.
    Li D; Qin Q; Wang XY; Shi HS; Luo M; Guo FC; Wang W; Wang YS
    Oncol Rep; 2014 Mar; 31(3):1287-95. PubMed ID: 24378474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-inflammatory signaling by mammary tumor cells mediates prometastatic macrophage polarization in an innovative intraductal mouse model for triple-negative breast cancer.
    Steenbrugge J; Breyne K; Demeyere K; De Wever O; Sanders NN; Van Den Broeck W; Colpaert C; Vermeulen P; Van Laere S; Meyer E
    J Exp Clin Cancer Res; 2018 Aug; 37(1):191. PubMed ID: 30111338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imatinib mesylate efficiently achieves therapeutic intratumor concentrations in vivo but has limited activity in a xenograft model of small cell lung cancer.
    Wolff NC; Randle DE; Egorin MJ; Minna JD; Ilaria RL
    Clin Cancer Res; 2004 May; 10(10):3528-34. PubMed ID: 15161712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FES kinase promotes mast cell recruitment to mammary tumors via the stem cell factor/KIT receptor signaling axis.
    Kwok E; Everingham S; Zhang S; Greer PA; Allingham JS; Craig AW
    Mol Cancer Res; 2012 Jul; 10(7):881-91. PubMed ID: 22589410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maintenance of Clonogenic KIT(+) Human Colon Tumor Cells Requires Secretion of Stem Cell Factor by Differentiated Tumor Cells.
    Fatrai S; van Schelven SJ; Ubink I; Govaert KM; Raats D; Koster J; Verheem A; Borel Rinkes IH; Kranenburg O
    Gastroenterology; 2015 Sep; 149(3):692-704. PubMed ID: 25962936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arthritis augments breast cancer metastasis: role of mast cells and SCF/c-Kit signaling.
    Das Roy L; Curry JM; Sahraei M; Besmer DM; Kidiyoor A; Gruber HE; Mukherjee P
    Breast Cancer Res; 2013 Apr; 15(2):R32. PubMed ID: 23577751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The serine protease inhibitor protease nexin-1 controls mammary cancer metastasis through LRP-1-mediated MMP-9 expression.
    Fayard B; Bianchi F; Dey J; Moreno E; Djaffer S; Hynes NE; Monard D
    Cancer Res; 2009 Jul; 69(14):5690-8. PubMed ID: 19584287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tumor bed effect: increased metastatic dissemination from hypoxia-induced up-regulation of metastasis-promoting gene products.
    Rofstad EK; Mathiesen B; Henriksen K; Kindem K; Galappathi K
    Cancer Res; 2005 Mar; 65(6):2387-96. PubMed ID: 15781654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naringenin prevents TGF-β1 secretion from breast cancer and suppresses pulmonary metastasis by inhibiting PKC activation.
    Zhang F; Dong W; Zeng W; Zhang L; Zhang C; Qiu Y; Wang L; Yin X; Zhang C; Liang W
    Breast Cancer Res; 2016 Apr; 18(1):38. PubMed ID: 27036297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein kinase C-beta inhibitor enzastaurin (LY317615.HCI) enhances radiation control of murine breast cancer in an orthotopic model of bone metastasis.
    Dudek AZ; Zwolak P; Jasinski P; Terai K; Gallus NJ; Ericson ME; Farassati F
    Invest New Drugs; 2008 Feb; 26(1):13-24. PubMed ID: 17805485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting myeloid-derived suppressor cells in combination with primary mammary tumor resection reduces metastatic growth in the lungs.
    Bosiljcic M; Cederberg RA; Hamilton MJ; LePard NE; Harbourne BT; Collier JL; Halvorsen EC; Shi R; Franks SE; Kim AY; Banáth JP; Hamer M; Rossi FM; Bennewith KL
    Breast Cancer Res; 2019 Sep; 21(1):103. PubMed ID: 31488209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.